Emotion recognition and inhibitory control in manifest and pre-manifest Huntington's disease: evidence from a new Stroop task

被引:0
作者
Thomas Hünefeldt [1 ]
Sabrina Maffi [2 ]
Simone Migliore [2 ]
Ferdinando Squitieri [2 ]
Marta Olivetti Belardinelli [1 ]
机构
[1] Sapienza University of Rome
[2] Huntington and Rare Diseases Unit, Fondazione IRCCS Casa Sollievo della Sofferenza
关键词
congruent word interference; emotion recognition; emotional valence; Huntington’s disease; incongruent word interference; inhibitory control; Stroop interference;
D O I
暂无
中图分类号
R742.2 [舞蹈病];
学科分类号
1002 ;
摘要
Huntington’s disease(HD) is a genetic neurodegenerative disorder that affects not only the motor but also the cognitive domain. In particular, cognitive symptoms such as impaired executive skills and deficits in recognizing other individuals’ mental state may emerge many years before the motor symptoms. This study was aimed at testing two cognitive hypotheses suggested by previous research with a new Stroop task created for the purpose: 1) the impairment of emotion recognition in HD is moderated by the emotions’ valence, and 2) inhibitory control is impaired in HD. Forty manifest and 20 pre-manifest HD patients and their age-and gender-matched controls completed both the traditional "Stroop Color and Word Test"(SCWT) and the newly created "Stroop Emotion Recognition under Word Interference Task"(SERWIT), which consist in 120 photographs of sad, calm, or happy faces with either congruent or incongruent word interference. On the SERWIT, impaired emotion recognition in manifest HD was moderated by emotion type, with deficits being larger in recognizing sadness and calmness than in recognizing happiness, but it was not moderated by stimulus congruency. On the SCWT, six different interference scores yielded as many different patterns of group effects. Overall our results corroborate the hypothesis that impaired emotion recognition in HD is moderated by the emotions’ valence, but do not provide evidence for the hypothesis that inhibitory control is impaired in HD. Further research is needed to learn more about the psychological mechanisms underlying the moderating effect of emotional valence on impaired emotion recognition in HD, and to corroborate the hypothesis that the inhibitory processes involved in Stroop tasks are not impaired in HD. Looking beyond this study, the SERWIT promises to make important contributions to disentangling the cognitive and the psychomotor aspects of neurological disorders. The research was approved by the Ethics Committee of the "Istituto Leonarda Vaccari", Rome on January 24, 2018.
引用
收藏
页码:1518 / 1525
页数:8
相关论文
共 19 条
  • [1] Biological and clinical manifestations of juvenile Huntington’s disease: a retrospective analysis[J] . Caterina Fusilli,Simone Migliore,Tommaso Mazza,Federica Consoli,Alessandro De Luca,Gaetano Barbagallo,Andrea Ciammola,Emilia Mabel Gatto,Martin Cesarini,Jose Luis Etcheverry,Virginia Parisi,Musallam Al-Oraimi,Salma Al-Harrasi,Qasem Al-Salmi,Massimo Marano,Jean-Paul Gerard Vonsattel,Umberto Sabatini,Georg Bernhard Landwehrmeyer,Ferdinando Squitieri.The Lancet Neurology . 2018 (11)
  • [2] Quality of Life in Huntington’s Disease: Critique and Recommendations for Measures Assessing Patient Health‐Related Quality of Life and Caregiver Quality of Life[J] . Tiago A. Mestre MD, MSc,Noelle E. Carlozzi PhD,Aileen K. Ho PhD,Jean‐Marc Burgunder MD,Francis Walker MD,Aileen M. Davis PhD,Monica Busse BSc, BSc (Med), Hons. MSc (Med), PhD,Lori Quinn EdD, PT,Filipe B. Rodrigues MD,Cristina Sampaio MD, PhD,Christopher G. Goetz MD,Esther Cubo MD,Pablo Martinez‐Martin PhD,Glenn T. Stebbins PhD.Move
  • [3] Dissociation between decision-making under risk and decision-making under ambiguity in premanifest and manifest Huntington’s disease[J] . Najia Adjeroud,Jeremy Besnard,Christophe Verny,Adriana Prundean,Clarisse Scherer,Bénédicte Gohier,Dominique Bonneau,Nicole El Massioui,Philippe Allain.Neuropsychologia . 2017
  • [4] Beyond emotion recognition deficits: A theory guided analysis of emotion processing in Huntington’s disease[J] . Catarina C. Kordsachia,Izelle Labuschagne,Julie C. Stout.Neuroscience and Biobehavioral Reviews . 2017
  • [5] Social cognition in Huntington’s disease: A meta-analysis[J] . Emre Bora,Dennis Velakoulis,Mark Walterfang.Behavioural Brain Research . 2016
  • [6] Assessing Impairment of Executive Function and Psychomotor Speed in Premanifest and Manifest Huntington's Disease Gene-expansion Carriers
    Larsen, Ida Unmack
    Vinther-Jensen, Tua
    Gade, Anders
    Nielsen, Jorgen Erik
    Vogel, Asmus
    [J]. JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY, 2015, 21 (03) : 193 - 202
  • [7] Disruption of Response Inhibition Circuits in Prodromal Huntington Disease[J] . Julia A. Rao,Deborah L. Harrington,Sally Durgerian,Christine Reece,Lyla Mourany,Katherine Koenig,Mark J. Lowe,Vincent A. Magnotta,Jeffrey D. Long,Hans J. Johnson,Jane S. Paulsen,Stephen M. Rao.Cortex . 2014
  • [8] Clinical Neurogenetics[J] . Yvette M. Bordelon.Neurologic Clinics . 2013 (4)
  • [9] Predictors of phenotypic progression and disease onset in premanifest and early-stage Huntington’s disease in the TRACK-HD study: analysis of 36-month observational data[J] . Sarah J Tabrizi,Rachael I Scahill,Gail Owen,Alexandra Durr,Blair R Leavitt,Raymund A Roos,Beth Borowsky,Bernhard Landwehrmeyer,Chris Frost,Hans Johnson,David Craufurd,Ralf Reilmann,Julie C Stout,Douglas R Langbehn.Lancet Neurology . 2013 (7)
  • [10] Executive Functions[J] . Adele Diamond.Annual Review of Psychology . 2013 (1)